Sep 13, 2021 AzurRx BioPharma has entered into an agreement to acquire First Wave Bio in a $229,000,000 deal.

AzurRx BioPharma based at Brooklyn, New York, United States.
“First Wave BioPharma is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.”

Acquirer’s Website: http://www.azurrx.com

First Wave Bio based at Ann Arbor, Michigan, United States. “First Wave BioPharma is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.”

Acquiree’s Website: http://www.firstwavebio.com